Suven Life Sciences Ltd (NSE: SUVEN) climbed 6.3% to Rs 248.35 on Tuesday, 9 June 2026, in active trade.
The move at a glance
- Day change: +6.34% to Rs 248.35
- The stock is about 17% below its 52-week high of Rs 300 and 100% above its 52-week low of Rs 124.
- One-year return: 5%
- Today's volume was roughly 0.3 times its recent daily average.
Latest reported financials
| Period | Revenue (Rs Cr) | Net Profit (Rs Cr) |
|---|---|---|
| Q4 FY26 | 8 | -45.6 |
| FY26 (full year) | 7 | -276.3 |
In Q4 FY26, revenue rose about 209% from a year earlier to Rs 8 Cr and the company posted a net loss of Rs 45.6 Cr. For the full year FY26, revenue grew about 7% to Rs 7 Cr.
What is behind the move
Recent coverage on the stock includes: "Sunil Singhania’s Abakkus Portfolio: 6 stocks rally up to 75% in CY26; 5 new buys added in Q4" (Economic Times, 2026-05-30).
Key ratios
ROE -78.8%, Debt/Equity 0.00, Promoter holding 70.2%.
--- This article is for educational purposes only and is not investment advice. The figures above are drawn from company filings and exchange data and may contain errors, restatements or timing differences, so please verify against the primary source before relying on them. Stocks Sena is not a SEBI-registered investment adviser.